We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Oscient Files Patent Suit Over Cholesterol Drug

Law360 (January 15, 2009, 12:00 AM EST) -- Oscient Pharmaceuticals Corp. and Ethypharm SA have launched a patent infringement lawsuit against Lupin Ltd. over the cholesterol drug Antara.

The lawsuit, filed Wednesday in the U.S. District Court for the District of Maryland, was a response to a Paragraph IV certification notice Oscient received last month notifying it that Lupin had filed an abbreviated new drug application with the U.S. Food and Drug Administration seeking agency authorization to market a generic version of Antara.

Lupin is looking to sell generic Antara before the patent covering...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.